Urological cancer, Malmö
161 – 170 of 533
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Risk of Recurrent Disease 6 Years After Open or Robotic-assisted Radical Prostatectomy in the Prospective Controlled Trial LAPPRO
(
- Contribution to journal › Article
-
Mark
Treatment of High-grade Non–muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations : Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial “NIMBUS”
(
- Contribution to journal › Article
-
Mark
Introducing PIONEER : a project to harness big data in prostate cancer research
(
- Contribution to journal › Article
-
Mark
Cytokines and Janus kinase/signal transducer and activator of transcription signaling in prostate cancer : overview and therapeutic opportunities
(
- Contribution to journal › Scientific review
-
Mark
Targeted alpha therapy in a systemic mouse model of prostate cancer - a feasibility study
(
- Contribution to journal › Article
-
Mark
Assessing Radiographic Response to 223Ra with an Automated Bone Scan Index in Metastatic Castration-Resistant Prostate Cancer Patients
(
- Contribution to journal › Article
-
Mark
Scavenging of Labile Heme by Hemopexin Is a Key Checkpoint in Cancer Growth and Metastases
(
- Contribution to journal › Article
-
Mark
Hypoxia attenuates trastuzumab uptake and trastuzumab-emtansine (T-DM1) cytotoxicity through redistribution of phosphorylated caveolin-1
(
- Contribution to journal › Article
-
Mark
European Association of Urology Guidelines Office : How We Ensure Transparent Conflict of Interest Disclosure and Management
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Reelin Immunoreactivity in the Adult Spinal Cord : A Comparative Study in Rodents, Carnivores, and Non-human Primates
(
- Contribution to journal › Article